198 resultados para Antibióticos antituberculose
Resumo:
Pós-graduação em Biotecnologia - IQ
Resumo:
Pós-graduação em Biotecnologia - IQ
Resumo:
Pós-graduação em Zootecnia - FCAV
Resumo:
Pós-graduação em Bases Gerais da Cirurgia - FMB
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Introduction: Scientific evidence indicates that neonatal exposure to ototoxic drugs cause hearing loss in newborns. Objective: To characterize the use of ototoxic antibiotics in newborns (NB), treated in the Neonatal Intensive Care Unit (NICU) and evaluate possible hearing modifications. Methods: A descriptive cross-sectional quantitative approach, using data from medical records of infants who were at some time in the NICU and used antibiotics, including ototoxic, from January to June 2004 as much as 2010, and the data were compared and analyzed. Parents/guardians of infants born in 2004 were contacted and applied a questionnaire containing questions about the children’s hearing. These children were submitted to audiological evaluation. Results: There was significant reduction in the time of use, the amount of antibiotics prescribed to newborns and Vancomycin prescription in 2010 compared to 2004. The hearing tests of 13 born in 2004 showed: sensorineural hearing loss in only 2 (one with moderate hearing loss and descending configuration in pure tone audiometry and the other with bilateral cochlear impairment); audiometric thresholds within the normal range in 11 patients, and the presence of otoacoustic emissions in 9. In Evoked Auditory Brainstem Response (ABR) no changes were observed. Conclusion: The reduction in the time of use, the amount and types of antibiotics observed may be related to the adoption of a Protocol in 2008, by the service. In contrast, auditory alterations may be related to a neonatal exposure to antibiotics in 2004.
Resumo:
Pós-graduação em Química - IQ
Resumo:
Pós-graduação em Microbiologia Agropecuária - FCAV
Resumo:
Due to the complexity and instability of clinical conditions of ICU patients, the drug therapy applied in this type of environment requires a combination of several prescribed drugs, which is a favorable condition for drug interaction, toxic synergism and possible iatrogenia. In the possible universe of ICU occurrences, this study aimed at identifying and evaluating the incidence of adverse events in drug therapy at the Intensive Care Therapy Service (SETI) in wards I and II. It is a cross-sectional, descriptive, prospective and quantitative study conducted from August to September, 2011 in the Intensive Care Service of the Botucatu School of Medicine University Hospital - UNESP. The population consisted of fifteen clinical nurses, including those in the Improvement and Volunteer Internship Programs, who contributed to the investigation after signing an informed consent form and according to approval by the Research Ethics Committee number 10711/CE - FMB. The data were entered on a form and analyzed. Results showed that, on average, 8.9% of events/day occurred, and the highest frequency was observed on August 04, 2011. 63% and 22% were respectively observed in the morning and afternoon shifts, and 15% in the night shift. 48% of these were due to administration time errors, followed by drug prescription and dispensation errors, with percentages of 22% and 18%, respectively. Antibiotics showed the highest frequency of adverse events - 18%, which was followed by 13% for anticoagulant, 11% for antiemetic and 10% for antiulcerative drugs. As regards the occurrence of adverse events related to hospitalization time, the highest frequency occurred in patients who were hospitalized for 10 days. Concerning the ratio between reported events and the number of items in the prescription, the highest frequency of events was related to prescriptions with 20 items... (Complete abstract click electronic access below)
Resumo:
Photodynamic therapy, term introduced by von Tapeiner in 1900, can be defined as the administration of a non toxic drug, i.e., a dye, known as photosensitizer (FS), which subsequently will be illuminated with light of specific wavelength. PDT is based on the interaction among FS, oxygen and light, which through photochemical reactions cause cell death. The FS molecules must have a high probability to form the singlet state after the excitation, which can induce chemical changes in the neighborhood in two ways, called reactions type I and type II. The type II reaction is based on the exchange of energy to molecular oxygen, exciting it to its state of higher energy (singlet), which is highly reactive. The proposed mechanisms for cell death are linked to damage to the DNA, mitochondria and to the cytoplasmic membrane. Several pre‐clinical and clinical trials have been carried out and the PDT is already used in many countries for treatment mainly against certain types of cancer. The therapy also has been gaining strength in antimicrobial control, since the microorganisms have appeared increasingly resistant to current antibiotics. Another attempt to use the PDT is for the inactivation of macro‐organisms, such as micro‐crustaceans and mosquitoes. To this end I tested whether the photosensitizers methylene blue, rose Bengal and the chlorophyll a has insecticidal activity against the yellow fever and dengue vector mosquito, Aedes aegypti. Since these diseases have no effective treatments, its control is linked to the vector control, which has shown resistance to chemical pesticides used. Based on this, this work shows its importance, because it is a new type of mosquito control since all the photosensitizers used are low cost, do not generate toxic products at the concentrations used and showed good results in mortality. The best photosensitizer was rose Bengal... (Complete abstract click electronic access below)
Resumo:
Atualmente o uso indiscriminado e não criterioso de antibióticos está causando um aumento alarmante de resistência bacteriana chegando a ser considerado um problema de saúde pública. Nesse contexto, a utilização do peptídeo antimicrobiano (PAM) Hylina-a1 proveniente de uma rã da fauna brasileira está sendo estudado. Sua atuação na membrana celular dificulta a ocorrência de resistência bacteriana. No entanto, o uso de PAMs ainda apresenta problemas principalmente relacionados à disponibilidade, eficácia e toxicidade. A fim de contornar esses problemas, este trabalho teve como objetivo principal avaliar a incorporação deste peptídeo a um sistema líquido cristalino nanoestruturado com capacidade de regular a liberação e proteger os peptídeos da degradação química e física mantendo a bioatividade. O sistema líquido cristalino foi preparado com fosfatidilcolina de soja (FS), oleato de sódio (OS) e Tween 20 (TW), colesterol (CHO) e tampão fosfato, sendo que alguns pontos apresentaram fases líquido-cristalinas do tipo lamelar. Para os estudos posteriores foi escolhido um ponto com características visuais de viscosidade apropriadas ao uso tópico e a este se incorporou o peptídeo. A obtenção do peptídeo por meio da SPFS foi viável, obtendo-se materiais com alto índice de pureza. No ensaio de reologia a formulação apresentou-se como fluido pseudoplástico não–Newtoniano, com a presença de tixotropia; sendo possível também confirmar a incorporação do peptídeo ao sistema. A espectroscopia UV e a CLAE comprovaram que a maior parte do peptídeo é incorporada à fase líquido-cristalina do sistema. Os ensaios biológicos mostraram que o sistema líquido-cristalino possui atividade contra bactérias muito menor que o peptídeo livre. Este fato foi atribuído à baixa liberação do peptídeo pelo sistema
Resumo:
As formigas da tribo Attini apresentam reconhecida simbiose com microrganismos: fungos mutualistas basidiomicetos nas famílias Lepiotaceae e Pterulaceae cultivados pelas formigas, bactérias actinomicetas ou no gênero Burkholderia produtoras de antibióticos contra fungos entomopatogênicos, fungos ascomicetos do gênero Escovopsis micófagos para o mutualista, e comensais como fungos, leveduras e bactérias que degradam celulose. Um novo mutualista é descrito no presente trabalho: uma espécie de bactéria no gênero Mesoplasma, detectada via PCR para 16S no DNA genômico de Attini derivadas (gêneros Acromyrmex, Atta, Serycomyrmex e Cyphomyrmex), intermediárias (Trachymyrmex) e basais (Apterostigma, Mycetarotes, Mycocepurus e Mycetagroicos). Uma única linhagem de Mesoplasma com baixíssima diversidade 16S esteve presente nas Attini, mas não em formigas de tribos filogeneticamente próximas a Attini, como Dolichoderini (Tapinoma sp), Camponotini (Camponotus sp), Cephalotini (Cephalotes sp), Crematogastrini (Crematogaster sp), Pheidolini (Pheidole sp) e Ponerini (Pachycondyla sp), indicando uma simbiose Mesoplasma-Attini recente e específica.
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)